Programming of Intestinal Epithelial Differentiation by IL-33 Derived from Pericryptal Fibroblasts in Response to Systemic Infection.

[1]  M. Neurath,et al.  Loss of Survivin in Intestinal Epithelial Progenitor Cells Leads to Mitotic Catastrophe and Breakdown of Gut Immune Homeostasis. , 2016, Cell reports.

[2]  R. Locksley,et al.  Tuft-cell-derived IL-25 regulates an intestinal ILC2–epithelial response circuit , 2015, Nature.

[3]  O. Klein,et al.  Opposing activities of Notch and Wnt signaling regulate intestinal stem cells and gut homeostasis. , 2015, Cell reports.

[4]  J. Gangneux,et al.  Crucial and Diverse Role of the Interleukin-33/ST2 Axis in Infectious Diseases , 2015, Infection and Immunity.

[5]  Samuel I. Miller,et al.  Temporal and Anatomical Host Resistance to Chronic Salmonella Infection Is Quantitatively Dictated by Nramp1 and Influenced by Host Genetic Background , 2014, PloS one.

[6]  P. Dempsey,et al.  ADAM10 regulates Notch function in intestinal stem cells of mice. , 2014, Gastroenterology.

[7]  S. Magness,et al.  Defining hierarchies of stemness in the intestine: evidence from biomarkers and regulatory pathways. , 2014, American journal of physiology. Gastrointestinal and liver physiology.

[8]  Yasmine Belkaid,et al.  The Alarmin IL-33 Promotes Regulatory T Cell Function in the Intestine , 2014, Nature.

[9]  Tomohiro Mizutani,et al.  Distinct expression patterns of Notch ligands, Dll1 and Dll4, in normal and inflamed mice intestine , 2014, PeerJ.

[10]  M. Teixeira,et al.  IL-33 targeting attenuates intestinal mucositis and enhances effective tumour chemotherapy in mice , 2014, Mucosal Immunology.

[11]  Michael U. Martin.  Special aspects of interleukin-33 and the IL-33 receptor complex. , 2013, Seminars in immunology.

[12]  D. Voehringer,et al.  Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. , 2013, Immunity.

[13]  L. Lopetuso,et al.  Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease , 2013, Front. Immunol..

[14]  M. Vecchi,et al.  The Role of IL-33 in Gut Mucosal Inflammation , 2013, Mediators of inflammation.

[15]  H. Turnquist,et al.  Implications for Interleukin-33 in solid organ transplantation. , 2013, Cytokine.

[16]  S. Koyasu,et al.  Th2‐type innate immune responses mediated by natural helper cells , 2013, Annals of the New York Academy of Sciences.

[17]  T. Wynn,et al.  IL-33-induced alterations in murine intestinal function and cytokine responses are MyD88, STAT6, and IL-13 dependent. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[18]  N. Shroyer,et al.  Notch in the intestine: regulation of homeostasis and pathogenesis. , 2013, Annual review of physiology.

[19]  K. Mertz,et al.  Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice , 2012, Gut.

[20]  F. Cominelli,et al.  New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation. , 2012, Cytokine.

[21]  I. Udalova,et al.  The alarmin IL-33 is a notch target in quiescent endothelial cells. , 2012, The American journal of pathology.

[22]  S. Vogel,et al.  Transcriptional Regulation of Murine IL-33 by TLR and Non-TLR Agonists , 2012, The Journal of Immunology.

[23]  K. Hase,et al.  Epithelial Cell-Intrinsic Notch Signaling Plays an Essential Role in the Maintenance of Gut Immune Homeostasis , 2012, The Journal of Immunology.

[24]  P. Dempsey,et al.  Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells , 2012, Development.

[25]  Freddy Radtke,et al.  Rorα is essential for nuocyte development , 2011, Nature Immunology.

[26]  K. Isse,et al.  IL-33 Expands Suppressive CD11b+ Gr-1int and Regulatory T Cells, including ST2L+ Foxp3+ Cells, and Mediates Regulatory T Cell-Dependent Promotion of Cardiac Allograft Survival , 2011, The Journal of Immunology.

[27]  Y. Naito,et al.  Interleukin-33 suppresses Notch ligand expression and prevents goblet cell depletion in dextran sulfate sodium-induced colitis. , 2011, International journal of molecular medicine.

[28]  Rudi Beyaert,et al.  Enterocyte death and intestinal barrier maintenance in homeostasis and disease. , 2011, Trends in molecular medicine.

[29]  Hans Clevers,et al.  Isolation and in vitro expansion of human colonic stem cells , 2011, Nature Medicine.

[30]  J. Harrow,et al.  A conditional knockout resource for the genome-wide study of mouse gene function , 2011, Nature.

[31]  G. Rogler,et al.  A role for interleukin-33 in TH2-polarized intestinal inflammation? , 2011, Mucosal Immunology.

[32]  A. Ouellette.  Paneth cell α-defensins in enteric innate immunity , 2011, Cellular and Molecular Life Sciences.

[33]  C. Gabay,et al.  Interleukin-33 biology with potential insights into human diseases , 2011, Nature Reviews Rheumatology.

[34]  K. Kaestner,et al.  Dll1- and dll4-mediated notch signaling are required for homeostasis of intestinal stem cells. , 2011, Gastroenterology.

[35]  Hans Clevers,et al.  Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts , 2011, Nature.

[36]  M. Vatn,et al.  Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. , 2010, The American journal of pathology.

[37]  David Díaz-Jiménez,et al.  Characterization of the novel ST2/IL‐33 system in patients with inflammatory bowel disease , 2010, Inflammatory bowel diseases.

[38]  F. Liew,et al.  Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection , 2010, Nature Medicine.

[39]  A. Andoh,et al.  Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis , 2010, Journal of Gastroenterology.

[40]  C. Fiocchi,et al.  Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis , 2010, Proceedings of the National Academy of Sciences.

[41]  I. McInnes,et al.  Disease-associated functions of IL-33: the new kid in the IL-1 family , 2010, Nature Reviews Immunology.

[42]  J. Kanellopoulos,et al.  IL-33 Enhances Lipopolysaccharide-Induced Inflammatory Cytokine Production from Mouse Macrophages by Regulating Lipopolysaccharide Receptor Complex1 , 2009, The Journal of Immunology.

[43]  H. Clevers,et al.  Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche , 2009, Nature.

[44]  J. Pollheimer,et al.  Interleukin-33 - cytokine of dual function or novel alarmin? , 2009, Trends in immunology.

[45]  B. Finlay,et al.  Chronic enteric salmonella infection in mice leads to severe and persistent intestinal fibrosis. , 2008, Gastroenterology.

[46]  XuD HepworthMR LiewFY GrencisRK HumphreysNE.  IL-33, a potent inducer of adaptive immunity to intestinal nematodes. , 2008 .

[47]  H. Clevers,et al.  Identification of stem cells in small intestine and colon by marker gene Lgr5 , 2007, Nature.

[48]  F. O'Gara,et al.  Construction of p16Slux, a Novel Vector for Improved Bioluminescent Labeling of Gram-Negative Bacteria , 2007, Applied and Environmental Microbiology.

[49]  V. Lievin-Le Moal,et al.  The Front Line of Enteric Host Defense against Unwelcome Intrusion of Harmful Microorganisms: Mucins, Antimicrobial Peptides, and Microbiota , 2006, Clinical Microbiology Reviews.

[50]  J Fernando Bazan,et al.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.

[51]  S. Artavanis-Tsakonas,et al.  Notch signals control the fate of immature progenitor cells in the intestine , 2005, Nature.

[52]  V. Krizhanovsky,et al.  Math1 controls cerebellar granule cell differentiation by regulating multiple components of the Notch signaling pathway , 2004, Development.

[53]  M. Hogardt,et al.  Pretreatment of Mice with Streptomycin Provides a Salmonella enterica Serovar Typhimurium Colitis Model That Allows Analysis of Both Pathogen and Host , 2003, Infection and Immunity.

[54]  H. Zoghbi,et al.  Requirement of Math1 for Secretory Cell Lineage Commitment in the Mouse Intestine , 2001, Science.

[55]  I. Lawrance,et al.  Altered Response of Intestinal Mucosal Fibroblasts to Profibrogenic Cytokines in Inflammatory Bowel Disease , 2001, Inflammatory bowel diseases.

[56]  C. Billington,et al.  Regulation of proliferation of human colonic subepithelial myofibroblasts by mediators important in intestinal inflammation. , 1998, The Journal of clinical investigation.

[57]  D. Malo,et al.  The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene , 1995, The Journal of experimental medicine.

[58]  S. Nakae,et al.  IL-33 and IL-33 receptors in host defense and diseases. , 2010, Allergology international : official journal of the Japanese Society of Allergology.

[59]  茂呂 和世.  Innate production of T[H]2 cytokines by adipose tissue-associated c-Kit[+]Sca-1[+] lymphoid cells , 2010 .

[60]  S. Targan,et al.  Role of cytokines in the pathogenesis of inflammatory bowel disease. , 2000, Annual review of medicine.

[61]  Ryoichiro Kageyama,et al.  Control of endodermal endocrine development by Hes-1 , 2000, Nature Genetics.

[62]  V. Krizhanovsky,et al.  Math 1 controls cerebellar granule cell differentiation by regulating multiple components of the Notch signaling pathway , 2022 .